Nurse scientist and advanced practice registered nurse contributions to oncology clinical trials within the National Cancer Institute Cooperative Group infrastructure Authors: Jamie S. Myers Published: 2026 This special issue of the Asia–Pacific Journal of Oncology Nursing provides a pertinent vehicle for highlighting the important contributions of nurses to oncology research. Nurses serve in a multitude of roles for conducting and supporting oncology clinical trials. Nurses prepared at the doctoral level (e.g., PhD, DNP, DNSc) such as nurse scientists and advanced practice registered nurses (APRNs), have made significant contributions to the state of the knowledge for cancer survivorship by conducting their own investigator-initiated research and facilitating enrollment in oncology clinical trials being conducted by others. These contributions are in evidence for nurse scientists and APRNs conducting research at single institutions and for those conducting multi-site research within a cooperative group structure. Additionally, nurses serve in a variety of leadership roles within cooperative groups that also result in important contributions to oncology research. The focus of this editorial paper is to highlight just a few of the significant research contributions made by nurses serving in leadership roles within the United States National Cancer Institute (NCI)-funded Research Bases (also referred to as cooperative groups). These examples are not a comprehensive list but will serve as examples of how oncology nurses forge the evidence that guides cancer survivorship care. National Cancer Institute (NCI) Cooperative Group evolution Cancer Cooperative Groups within the United States were founded in the 1950s to provide an infrastructure to conduct multi-institutional cancer clinical trials. The cooperative groups are funded by the NCI and include a network comprised of both academic institutions and community cancer centers. A detailed review of the evolution to the current organizational structure has been published previously.1 In brief, following an Institute of Medicine report the earlier US Cooperative Group Program infrastructure (that included the Community Clinical Oncology Program—CCOP) was redesigned into the NCI National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). Within this new structure, existing cooperative groups were aggregated into fewer entities (Table 1) in 2014.Table 1Aggregation of the cooperative groups.Table 1Former cooperative groupsCurrent cooperative groupsAmerican College of Surgeons Clinical Oncology Group (ACOSOG)Alliance for Clinical Trials in Oncology (Alliance)Cancer and Leukemia Group B (CALGB)North Central Cancer Treatment Group (NCCTG)Eastern Clinical Oncology Group (ECOG)ECOG-ACRINAmerican College of Radiology Imaging Network (ACRIN)National Surgical Adjuvant Breast and Bowel Project (NSABP)NRG OncologyRadiation Therapy Oncology Group (RTOG)Gynecologic Oncology Group (GOG)Children's Oncology Group (COG)COGSouthwest Oncology Group (SWOG)SWOG Cancer Research Network Table 1Aggregation of the cooperative groups.Table 1Former cooperative groupsCurrent cooperative groupsAmerican College of Surgeons Clinical Oncology Group (ACOSOG)Alliance for Clinical Trials in Oncology (Alliance)Cancer and Leukemia Group B (CALGB)North Central Cancer Treatment Group (NCCTG)Eastern Clinical Oncology Group (ECOG)ECOG-ACRINAmerican College of Radiology Imaging Network (ACRIN)National Surgical Adjuvant Breast and Bowel Project (NSABP)NRG OncologyRadiation Therapy Oncology Group (RTOG)Gynecologic Oncology Group (GOG)Children's Oncology Group (COG)COGSouthwest Oncology Group (SWOG)SWOG Cancer Research Network Aggregation of the cooperative groups. NCI grant cycles are separate for the NCTN Network Operations Groups and the NCORP Research Bases. The NCTN grant primarily funds disease-specific clinical trials. The NCORP Research Base grant funds Cancer Prevention and Control studies (e.g., Cancer Care Delivery, Symptom Management and Cancer Survivorship, Palliative Care). Examples of cooperative group nurse leaders and oncology nurse contributions to cancer research Deborah Watkins Bruner, RN, PhD, FAAN, Former Vice President for Research, Emory University, Atlanta, GA. Dr. Bruner is internationally known for her research and has been continually funded since 1998 by numerous funders (e.g., The National Institutes of Health, American Cancer Society, and the United States Department of Defense). She was Principal Investigator for the RTOG Community Clinical Oncology Program prior to the merging of the cooperative groups. She is the first nurse ever to serve as the lead Principal Investigator for the NCI Clinical Trials Cooperative Groups. She now serves as Multiple Principal Investigator (MPI) for the NRG Oncology- NCORP. Debra L. Barton, PhD, RN, FAAN. Associate Dean for Research, Mary Lou Willard French Professor of Oncology Nursing, University of Michigan. Dr. Barton was one of the first nurses to serve as Principal Investigator for research being conducted within the cooperative group network. The National Institutes of Health Division of Cancer Prevention describes Dr. Barton as “one of the most prolific nurse scientists conducting research in the NCORP” and recognizes her contributions to cancer symptom management. Her work has informed the prevention and treatment of symptoms including hot flashes, fatigue, nausea, peripheral neuropathy, cognitive changes, and sleep disturbance. In 2014, she published important results from a two-arm randomized, placebo-controlled, double-blind, phase III trial evaluating the use of Ginkgo biloba for the mitigation of cognitive changes experienced by women treated for breast cancer (n = 226).2 This study was conducted via the NCCTG (prior to the merging of the cooperative groups) and The Mayo Clinic. This early work in the area of herbal therapies for cancer-related cognitive impairment provided important information to the state of the knowledge regarding the lack of evidence for use of Ginkgo biloba for this indication. Dr. Barton served two terms as Chair of the NCI Symptom Management and Quality of Life Steering Committee and now is a representative from the NRG NCORP Research Base. Diane Von Ah, PhD, RN, FAAN, Mildred E. Newton Endowed Professor, Distinguished Professor of Cancer Research, Center for Healthy Aging, Self-Management and Complex Care, College of Nursing, The Ohio State University. Dr. Von Ah is serving as Principal Investigator for a phase III trial being conducted within NRG Oncology. Dr. Von Ah is leading NRG-CC011, Cognitive Training for Cancer-Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial (n = 386). Dr. Von Ah's strong pilot work in this space provided the necessary support to obtain NCI funding to conduct this important interventional study for breast cancer survivors experiencing cognitive changes.3 Virginia Sun, PhD, RN, Professor, Department of Population Sciences and Department of Surgery for City of Hope, Duarte CA. Dr. Sun serves as Executive Director for the SWOG Cancer Research Network's Palliative Care and Symptom Management and Survivorship Research Committees. Dr. Sun served as Study Chair/Principal Investigator for SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer (AIMS-RC). This multisite, randomized, controlled study (n = 93) was conducted via the NCI NCORP Research Base of the SWOG Cancer Research Network, an NCI-supported NCTN). The study results demonstrated the protocol was feasible and the AIMS-RC intervention was highly acceptable to patients with rectal cancer.4 Improvements were seen in low anterior resection surgery (LARS) and frequency of bowel function. These study results will inform subsequent phase III effectiveness trials. Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, FAPO, Nurse Practitioner and Associate Research Specialist (Associate Professor), University of Hawaii Cancer Center; clinical faculty for the University of Hawaii School of Nursing and Dental Hygiene. Dr. Braun-Inglis serves as the MPI for the Hawaii NCORP and leads their Cancer Care Delivery Research. Dr. Braun-Inglis Co-Chairs the SWOG Advanced Practice and Nurse Scientist Committee with Jamie Myers, PhD, RN, AOCNS, FAAN (University of Kansas School of Nursing). Dr. Braun-Inglis is the Study Chair/Principal Investigator for a study being conducted within the Wake Forest NCORP. This study, WF-2403, is entitled Building Capacity within the NCORP Network through an Education and Mentorship Intervention for Advanced Practice Providers (APPs). This important work was informed by her strong pilot evidence and is investigating the impact of a structured mentoring program compared to attention control for increasing APPs’ research self-efficacy.5 Together with Dr. Myers, Dr. Braun-Inglis also is leading the SWOG Mentoring Advanced Practice Providers initiative (MAPP) (funded by Gilead, Inc. and The Hope Foundation). Dr. Braun-Inglis is dedicated to facilitating the full integration of APPs within the cooperative group infrastructure and ensuring that APPs may practice to the full scope of their licensure for the conduct and support of oncology research. Marie Bakitas, DNSc, RN, FAAN, Professor, Associate Director, Center for Palliative and Supportive Care, The University of Alabama at Birmingham. Dr. Bakitas is internationally recognized for her research in palliative care. She developed the ENABLE (Educate, Nurture, Advise, Before Life Ends) telehealth palliative care model which has led to practice and policy changes. She serves as Co-Chair of the SWOG Palliative Care Committee. In this role she is responsible for facilitating the navigation of palliative care related investigator-initiated research concepts through the cooperative group approval process, with subsequent review by the NCI Steering Council for potential funding. Together with Dr. Virginia Sun, Dr. Braun-Inglis, and Dr. Myers, she has provided leadership and support of the SWOG Advanced Practice Provider Task Force, and subsequent approval of the SWOG Advanced Practice Provider and Nurse Scientist Committee. In summary, nurse scientists have a long-standing history of leadership within the Cooperative Groups and have conducted research yielding significant evidence to shape practice for cancer survivorship care. Integration of APPs, including advanced practice nurses, into the fabric of the Cooperative Group infrastructure is more nascent, but has the potential to substantially expand clinical trial recruitment and supportive care research. Although this editorial focuses primarily on nurse scientists and APRNs, their leadership depends on and strengthens the broader clinical research nursing workforce, including nurses who support trial implementation, patient education, recruitment, retention, symptom monitoring, and protocol adherence. Strengthening these interconnected nursing roles may help advance more inclusive, nurse-led, and patient-centered oncology clinical trials across diverse health systems. Declaration of generative AI and AI-assisted technologies in the writing process No AI tools/services were used during the preparation of this work. Funding This work received no external funding. Declaration of competing interest The author declares no competing financial interests. The author is Co-Chair of the SWOG Cancer Research Network Advanced Practice Provider and Nurse Scientist Committee. The article has undergone the journal's standard publication procedures.